Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1–34) on chondrogenesis in a model of experimental fracture healing
- 1 November 2005
- Vol. 37 (5) , 711-719
- https://doi.org/10.1016/j.bone.2005.06.013
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 32 references indexed in Scilit:
- Mechanisms for the Enhancement of Fracture Healing in Rats Treated With Intermittent Low-Dose Human Parathyroid Hormone (1–34)Journal of Bone and Mineral Research, 2002
- Human PTH (1-34) induces longitudinal bone growth in ratsJournal of Bone and Mineral Metabolism, 2002
- Effects of Daily Treatment with Parathyroid Hormone on Bone Microarchitecture and Turnover in Patients with Osteoporosis: A Paired Biopsy StudyJournal of Bone and Mineral Research, 2001
- Spatial and temporal gene expression in chondrogenesis during fracture healing and the effects of basic fibroblast growth factorJournal of Orthopaedic Research, 2001
- Inhibition of Chondrogenesis by Parathyroid Hormone In Vivo During Repair of Full‐Thickness Defects of Articular CartilageJournal of Bone and Mineral Research, 2000
- Parathyroid Hormone–Related Protein Regulates Proliferation of Condylar Hypertrophic ChondrocytesJournal of Bone and Mineral Research, 1999
- Intermittent Parathyroid Hormone (1–34) Treatment Increases Callus Formation and Mechanical Strength of Healing Rat FracturesJournal of Bone and Mineral Research, 1999
- SOX9 directly regulates the type-ll collagen geneNature Genetics, 1997
- Localization and Quantification of Proliferating Cells During Rat Fracture Repair: Detection of Proliferating Cell Nuclear Antigen by ImmunohistochemistryJournal of Bone and Mineral Research, 1997
- Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormoneJournal of Bone and Mineral Research, 1991